Ozaki Kei-ichi | Laboratory Of Cell Regulation Department Of Pharmaceutical Sciences Graduate School Of Biomedical Sc
スポンサーリンク
概要
- OZAKI Kei-ichiの詳細を見る
- 同名の論文著者
- Laboratory Of Cell Regulation Department Of Pharmaceutical Sciences Graduate School Of Biomedical Scの論文著者
関連著者
-
Kohno Michiaki
Laboratory Of Cell Regulation Department Of Pharmaceutical Sciences Graduate School Of Biomedical Sc
-
Ozaki Kei-ichi
Laboratory Of Cell Regulation Department Of Pharmaceutical Sciences Graduate School Of Biomedical Sc
-
Tanimura Susumu
Laboratory Of Cell Regulation Department Of Pharmaceutical Sciences Graduate School Of Biomedical Sc
-
OZAKI Kei-ichi
Laboratory of Cell Regulation, Department of Pharmaceutical Sciences, Graduate School of Biomedical
-
KISHIKAWA Futaba
Laboratory of Cell Regulation, Department of Pharmaceutical Sciences, Graduate School of Biomedical
-
TANAKA Masashi
Laboratory of Cell Regulation, Department of Pharmaceutical Sciences, Graduate School of Biomedical
-
SAKAMOTO Toshiaki
Laboratory of Cell Regulation, Department of Pharmaceutical Sciences, Graduate School of Biomedical
-
TANIMURA Susumu
Laboratory of Cell Regulation, Department of Pharmaceutical Sciences, Graduate School of Biomedical
-
Kishikawa Futaba
Laboratory Of Cell Regulation Department Of Pharmaceutical Sciences Graduate School Of Biomedical Sc
-
Sakamoto Toshiaki
Laboratory Of Cell Regulation Department Of Pharmaceutical Sciences Graduate School Of Biomedical Sc
-
Tanaka Masashi
Laboratory Of Cell Regulation Department Of Pharmaceutical Sciences Graduate School Of Biomedical Sc
-
Ozaki Kei-ichi
Laboratory of Cell Regulation, Department of Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Nagasaki University
著作論文
- Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross-resistance to a wide range of DNA-damaging drugs
- Targeting the Extracellular Signal-Regulated Kinase Pathway in Cancer Therapy (Target Therapy for Cancer : Anti-cancer Drugs Targeting Growth-Factor Signaling Molecules)
- Targeting the Extracellular Signal-Regulated Kinase Pathway in Cancer Therapy